WILATE human coagulation factor VIII 450IU and von Willebrand factor 400 IU powder for injection vial with diluent vial

Riik: Austraalia

keel: inglise

Allikas: Department of Health (Therapeutic Goods Administration)

Toimeaine:

Von willebrand factor, Quantity: 400 IU; Factor VIII, Quantity: 7.5 mg; Factor VIII, Quantity: 450 IU

Saadav alates:

Octapharma Australia Pty Ltd

INN (Rahvusvaheline Nimetus):

Factor VIII,Von willebrand factor

Ravimvorm:

Injection, powder for

Koostis:

Excipient Ingredients: tributyl phosphate; sucrose; sodium citrate dihydrate; sodium chloride; calcium chloride dihydrate; octoxinol 9; glycine

Manustamisviis:

Intravenous

Näidustused:

1. Von Willebrand disease (VWD): treatment of bleeding episodes including surgical bleeding in patients with von Willebrand's disease when desmorpressin treatment is effective or contraindicated. 2. Haemophilia A: treatment and prophylaxis of bleeding including surgical bleeding in patients with haemophilia A (congenital FVIII deficiency). There are insifficient data to recommend the use of Wilate in children less than 12 years of age.

Toote kokkuvõte:

Visual Identification: White or pale yellow or friable solid.;

Volitamisolek:

Licence status A

Loa andmise kuupäev:

2007-09-26